屠呦呦
China Academy of Chinese Medical Sciences
For millennia, Chinese herbal medicine has tended to the sick through single-plant formulations. Today's researchers carry that care forward through papers, patents and the patient repetitions of experiment — translating it into the language of modern science.
This page lists fifty scholars who have spent careers in materia medica, TCM pharmacology and safety, TCM modernisation, aromatic herbs, TCM sleep medicine, sleep pharmacology, musculoskeletal care, and topical preparations. Their work, published in the open, is the most verifiable reference we have for the direction we call Zhiben Lab.
This page is a tribute to them — and to everyone else, unnamed here, who continues the same quiet work in herbal research.
Bibliographic records are kept in the original Chinese as publicly published to avoid mistranslation; romanised names are provided for lookup.
Grouped by research field. Expand a card for the scholar profile and sources; representative papers, granted patents and projects are indexed in the outputs section below.
China Academy of Chinese Medical Sciences
Institute of Materia Medica, CAMS
Shenyang Pharmaceutical University
Shanghai Institute of Materia Medica, CAS
Shanghai University of Traditional Chinese Medicine
Macau University of Science and Technology
China Academy of Chinese Medical Sciences
China Academy of Chinese Medical Sciences
China Academy of Chinese Medical Sciences
China Academy of Chinese Medical Sciences
Tianjin University of Traditional Chinese Medicine
China Academy of Chinese Medical Sciences
China Academy of Chinese Medical Sciences
Nanjing University of Chinese Medicine
China Academy of Chinese Medical Sciences
Beijing University of Chinese Medicine
Guangzhou University of Chinese Medicine
Jiangxi University of Chinese Medicine
Yunnan University of Chinese Medicine
Shanghai University of Traditional Chinese Medicine
Shanghai University of Traditional Chinese Medicine
China Academy of Chinese Medical Sciences
China Academy of Chinese Medical Sciences
Fujian Academy of Chinese Medical Sciences
Kunming Institute of Botany, CAS
Tianjin University of Traditional Chinese Medicine
Heilongjiang University of Chinese Medicine
Guizhou Minzu University
Nanjing University of Chinese Medicine
Henan University of Chinese Medicine
Shanghai University of Traditional Chinese Medicine
China Academy of Chinese Medical Sciences
Guangzhou University of Chinese Medicine
Zhejiang University of Chinese Medicine
Fudan University
Shanghai Institute of Materia Medica, CAS
Heilongjiang University of Chinese Medicine
Heilongjiang University of Chinese Medicine
China Academy of Chinese Medical Sciences
No matching records found.
Each item below has been verified against its original source page and relates directly to aromatic sleep support, herbal filling, hot compress and musculoskeletal care — serving as public technical reference during formulation and structural design.
以薰衣草、甜橙、檀香等芳香药配伍的复方安神精油,经吸入给药开展动物实验:小鼠自发活动减少、睡眠潜伏期缩短、睡眠时长延长,脑内 5-HT 与 GABA 含量升高。GC-MS 检出主成分为 D-柠檬烯 24.07%、芳樟醇 21.98%、乙酸芳樟酯 15.37%、α-蒎烯 5.39%、α-檀香醇 4.8%。
授权发明专利《镇静安神的中药组合物、中药缓释香囊及其制备方法》,公开配方由酸枣仁、栀子花、檀香、马乔莲、香蜂草、薰衣草、洋甘菊、橙花、甜橙、葡萄柚配伍,以挥发油经空气传播达到安神目的。为枕芯、草本包的组方与缓释结构设计提供公开可查的技术参照。
夜用香囊:合欢花 25—35%、夜交藤 25—35%、檀香 35—45%;昼用香囊:甘松 35—45%、薄荷 25—35%、玫瑰花 25—35%。原料粉碎过 24 目筛后分别装袋,通过「昼夜双方」帮助恢复寤寐节律。该思路对枕芯产品的分时配方设计具有直接参考价值。
纳入 34 项研究的随机效应模型 meta 分析:芳香吸入疗法对失眠等睡眠问题的效应量 ES=0.6491(95%CI),定量与定性睡眠指标均显著改善。亚组分析显示:单一精油优于复方混合精油,其中薰衣草效果最大;入睡前直接吸入效果最佳,吸入频次无显著差异;治疗次数越多效应越大。作者自述纳入研究存在较高的实施偏倚与选择偏倚风险。
「热敷+芳香」结合的授权发明专利。配方(重量百分比):还原铁粉 35—50%、膨胀蛭石 5—15%、艾草粉 3—10%、活性炭 8—17%、芳香精油 0.1—0.2%、工业盐 2—5%、水 8—18%、乙醇 1—2%;无纺布层经薰衣草熏制,原料层抽真空封装。芳香精油可选檀香、玫瑰、迷迭香、柠檬、薰衣草、洋甘菊、丁香、甜橙中的一种或多种。
网络药理学锁定 AKT1、PTGS2、ESR1 为关键候选靶点,分子对接显示伸筋草主成分 sitosterol、formononetin、stigmasterol、α-onocerin 与 STING 有良好结合活性。体外实验证实伸筋草抑制 IL-1β 介导的软骨细胞炎症介质分泌、凋亡与衰老;体内实验逆转 DMM 小鼠软骨退变,机制为抑制 STING/NF-κB 通路。原文仅报告「显著」,未给出具体百分比。
Academic papers, clinical trials and published patents grouped under three topics — Lycopodii Herba, herbal hot compress, and aroma and sleep — each annotated with study subjects and citable data. Granted patents and published applications are strictly distinguished.
伸筋草(石松科石松 Lycopodium japonicum)的化学成分、抗炎镇痛与骨关节保护机制,以及含伸筋草的外用制剂与药枕类公开专利。
中药热奄包、热熨敷联合穴位刺激的失眠与骨关节临床研究,以及自发热+中药/芳香精油结合的热敷类公开专利。
芳香吸入改善睡眠的系统评价与 meta 分析,以及草本热敷枕、加热型助眠枕、安神精油类公开专利。
Every attributed output with venue, year, role, verification status and external link. Filter by type, scholar or keyword.
| Type | Title | Venue / ID | Year | Role | Verification | Source |
|---|---|---|---|---|---|---|
| SCI Paper | The birth of artemisinin | Pharmacology & Therapeutics|PMID 32777330 | 2020 | 通讯作者(yytu@icmm.ac.cn) | Verified on PubMed record | Source |
| SCI Paper | Malaria: past, present, and future | Signal Transduction and Targeted Therapy|PMID 40523953 | 2025 | 作者 | Bibliographic record confirmed | Source |
| SCI Paper | The role of research in China's successful elimination of malaria | Nature Medicine|PMID 35641827 | 2022 | 作者 | Bibliographic record confirmed | Source |
| Granted Patent | 抗疟新药复方双氢青蒿素 | ZL99109669.X(公告号 CN1137683C) | 1999 | 第一发明人 | Bibliographic record confirmed | Source |
| Granted Patent | 治疗红斑狼疮和光敏性疾病的含双氢青蒿素的药物组合物 | ZL99103346.9(公告号 CN1116036C) | 1999 | 第一发明人 | Bibliographic record confirmed | Source |
| National Research Project | 国家“523”疟疾防治药物研究协作项目(任中药抗疟科研组组长) | 无公开统一编号 | 1969起 | 科研组组长 | Institutional / official media source | Source |
| SCI Paper | Effect of Yiqi Fumai lyophilized injection on BNP levels in acute decompensated ischemic heart failure | Phytomedicine|PMID 42013737 | 2026 | 通讯作者 | Bibliographic record confirmed | Source |
| SCI Paper | Targeting SARS-CoV-2 main protease for the discovery of a broad-spectrum COVID-19 inhibitor | Acta Pharmaceutica Sinica B|PMID 41311409 | 2025 | 合作作者 | Bibliographic record confirmed | Source |
| SCI Paper | Evidence Map Analysis on RCTs: Chinese Patent Medicines and Classic TCM Prescriptions | Journal of Evidence-Based Medicine|PMID 42394471 | 2026 | 合作作者 | Bibliographic record confirmed | Source |
| Granted Patent | 一种治疗急慢性心力衰竭的药物组合物制备方法及应用 | ZL200510015373.7 | 2005 | 发明人 | Bibliographic record confirmed | Source |
| Granted Patent | 一种治疗脂肪肝的药物组合物及制备方法应用 | ZL200610014371.0 | 2006 | 发明人 | Bibliographic record confirmed | Source |
| Granted Patent | 香加皮强心作用有效提取物、制备方法及用途 | 200410019975 | 2004 | 发明人 | Bibliographic record confirmed | Source |
| National Research Project | 973计划“方剂关键科学问题的基础研究” | G1999054400 | 1999 | 首席科学家 | Bibliographic record confirmed | Source |
| National Research Project | 973计划“治疗心血管疾病有效方剂组分配伍规律研究” | 编号未公开 | — | 首席科学家 | Institutional / official media source | Source |
| SCI Paper | Molecular pharmacognosy: a new borderline discipline | Natural Product Communications|PMID 19968001 | 2009 | 第一/通讯作者 | Bibliographic record confirmed | Source |
| SCI Paper | Molecular pharmacognosy | Science China Life Sciences|PMID 20602266 | 2010 | 作者 | Bibliographic record confirmed | Source |
| SCI Paper | The Gastrodia elata genome provides insights into plant adaptation to heterotrophy | Nature Communications|DOI 10.1038/s41467-018-03423-5 | 2018 | 合作作者 | Bibliographic record confirmed | Source |
| Granted Patent | 高特异性聚合酶链式反应技术鉴别中药材乌梢蛇真伪的方法 | ZL200410006374.0 | 2004 | 发明人 | Bibliographic record confirmed | Source |
| Granted Patent | 一种丹参二萜合酶基因及其编码产物与应用 | ZL200710100144.4 | 2007 | 发明人 | Bibliographic record confirmed | Source |
| Granted Patent | 鉴定金钱白花蛇的PCR方法及其特异引物 | ZL200910148598.8 | 2009 | 发明人 | Bibliographic record confirmed | Source |
| National Research Project | 国家自然科学基金重大项目“中药道地性研究”(中药领域首个NSFC重大项目) | 编号未公开 | — | 负责人 | Institutional / official media source | Source |
| National Research Project | 973计划“中药药性理论继承与创新研究” | 编号未公开 | — | 首席科学家 | Institutional / official media source | Source |
| SCI Paper | Genome sequence of the model medicinal mushroom Ganoderma lucidum | Nature Communications|PMID 22735441 | 2012 | 第一作者 | Bibliographic record confirmed | Source |
| SCI Paper | Cepharanthine analogs mining and genomes of Stephania accelerate anti-coronavirus drug discovery | Nature Communications|PMID 38378731 | 2024 | 通讯作者 | Bibliographic record confirmed | Source |
| Granted Patent | 一种获取rDNA ITS2序列用来对铁皮枫斗鉴定的方法 | CN106399475B | 2019 | 共同发明人 | Cross-verified in patent databases | Source |
| SCI Paper | Efficacy and safety of Mudan granules for treatment of diabetic peripheral neuropathy | Journal of Ethnopharmacology|PMID 42069162 | 2026 | 通讯作者(tongxiaolin@vip.163.com) | Verified on PubMed record | Source |
| SCI Paper | UHPLC/Q-TOF-MS-based blood-component profiling reveal mechanisms of Shenzhuo Formula against diabetic kidney disease | J Pharmaceutical and Biomedical Analysis|PMID 42385329 | 2026 | 通讯作者 | Bibliographic record confirmed | Source |
| SCI Paper | The effects of Gegen Qinlian decoction on glucolipid metabolic disorders in diabetes | Systematic Reviews|PMID 40739586 | 2025 | 通讯作者 | Bibliographic record confirmed | Source |
| Granted Patent | 一种治疗糖尿病的药物组合物和制备方法及其用途 | CN201811626580.X | 2018 | 第一发明人 | Bibliographic record confirmed | Source |
| Granted Patent | 一种治疗糖尿病周围神经病变的中药组合物及其应用 | CN202111403484.0 | 2021 | 发明人 | Bibliographic record confirmed | Source |
| National Research Project | 973计划“以量-效关系为主的经典名方相关基础研究” | 2010CB530601 | 2010 | 首席科学家 | Bibliographic record confirmed | Source |
| SCI Paper | Efficacy of Yuxintong capsule on cardiorespiratory fitness in patients with stable coronary heart disease | Journal of Ethnopharmacology|PMID 41500352 | 2026 | 作者 | Bibliographic record confirmed | Source |
| SCI Paper | Correlation Between Fat Attenuation Index and Major Adverse Cardiovascular Events | Reviews in Cardiovascular Medicine|PMID 42110165 | 2026 | 作者 | Bibliographic record confirmed | Source |
| National Research Project | 国家“八五/九五/十五”科技攻关课题及国家自然科学基金项目(活血化瘀方药干预冠心病介入后再狭窄系列研究) | 编号未公开 | — | 负责人 | Institutional / official media source | Source |
| SCI Paper | A decrease in Flavonifractor plautii and its product phytosphingosine predisposes individuals with phlegm-dampness constitution to metabolic disorders | Cell Discovery|PMID 40097405 | 2025 | 通讯作者 | Same-name risk — second check advised | Source |
| SCI Paper | Single-cell transcriptome analyses of PBMCs reveal immunological characteristics of phlegm-dampness constitution | Frontiers of Medicine|PMID 40126771 | 2025 | 通讯作者 | Same-name risk — second check advised | Source |
| SCI Paper | Obese Individuals With and Without Phlegm-Dampness Constitution Show Different Gut Microbial Composition | Frontiers in Cellular and Infection Microbiology|PMID 35719350 | 2022 | 通讯作者 | Same-name risk — second check advised | Source |
| Granted Patent | 痰湿调体方(化痰祛湿方,用于痰湿体质调理) | ZL201410538335.9 | 2014 | 发明人 | Cross-verified in patent databases | Source |
| Granted Patent | 中医体质辨识体系相关专利 | ZL202410706522.7 | 2024 | 发明人 | Bibliographic record confirmed | Source |
| National Research Project | 973计划“中医原创思维与健康状态辨识方法体系研究” | 2011CB505400 | 2011 | 首席科学家 | Bibliographic record confirmed | Source |
| National Research Project | 国家自然科学基金重点项目“痰湿体质易发代谢综合征的中医病因病机分子特征研究” | 81030064 | 2010 | 负责人 | Bibliographic record confirmed | Source |
| SCI Paper | Screening of hepatotoxic components of Epimedium brevicornu Maxim. by liver microfluidic-organ-chip | Journal of Ethnopharmacology|PMID 42341855 | 2026 | 通讯作者(gaoyue@bmi.ac.cn) | Bibliographic record confirmed | Source |
| SCI Paper | Advances in extraction, purification, and pharmacological mechanisms of calycosin | Chinese Journal of Natural Medicines|PMID 42215152 | 2026 | 通讯作者 | Bibliographic record confirmed | Source |
| SCI Paper | Crotonylation of ACAT1 K181 contributes to radioresistance by impacting lactate metabolism | Communications Biology|PMID 42587030 | 2026 | 通讯作者 | Bibliographic record confirmed | Source |
| Granted Patent | 一种基于高内涵技术的肾毒性检测方法及其应用 | CN113960302B | 2024 | 第一发明人 | Cross-verified in patent databases | Source |
| Granted Patent | 红景天提取物在能够刺激骨髓造血功能的药物中的应用 | CN93118728.1(已因未缴年费终止) | 1993 | 第一发明人 | Bibliographic record confirmed | Source |
| National Research Project | 973计划课题(中药配伍禁忌与毒性早期预测方向) | 2011CB505304 | 2011 | 负责人 | Bibliographic record confirmed | Source |
| SCI Paper | Penicimenolides A-F, Resorcylic Acid Lactones from Penicillium sp. | Scientific Reports|PMID 27271722 | 2016 | 通讯作者 | Bibliographic record confirmed | Source |
| SCI Paper | New alkylresorcinols from the fruits of Embelia ribes | Fitoterapia|PMID 29723563 | 2018 | 通讯作者 | Bibliographic record confirmed | Source |
| SCI Paper | Systematic screening of Qi-Li-Qiang-Xin capsule-related xenobiotics in rats | Journal of Chromatography B|PMID 29787993 | 2018 | 通讯作者 | Bibliographic record confirmed | Source |
| SCI Paper | Calamistrins A and B, two new cytotoxic monotetrahydrofuran annonaceous acetogenins | Journal of Natural Products|PMID 10075755 | 1999 | 通讯作者 | Same-name risk — second check advised | Source |
| SCI Paper | Donnaienin, a New Acetogenin Bearing a Hydroxylated Tetrahydrofuran Ring | Journal of Natural Products|PMID 9548832 | 1998 | 通讯作者 | Same-name risk — second check advised | Source |
| National Research Project | 国家科技攻关项目“人工麝香”研究 | 编号未公开 | 1975起 | 技术牵头单位骨干 | Institutional / official media source | Source |
| SCI Paper | Comparison of combination therapy with methotrexate and sinomenine or leflunomide for active rheumatoid arthritis | Phytomedicine|PMID 30851515 | 2019 | 通讯作者 | Bibliographic record confirmed | Source |
| SCI Paper | Multifunctional nanoparticles of sinomenine hydrochloride for treat-to-target therapy of rheumatoid arthritis | Journal of Controlled Release|PMID 35569587 | 2022 | 通讯作者 | Bibliographic record confirmed | Source |
| SCI Paper | Sinomenine versus NSAIDs for the treatment of rheumatoid arthritis | Planta Medica|PMID 18683125 | 2008 | 作者 | Bibliographic record confirmed | Source |
| Published Application | 盐酸青藤碱仿生纳米靶向体系(HA@M@PB@SIN NPs) | CN114306637A(仅检索到申请公布号) | 2022 | 团队发明人 | Bibliographic record confirmed | Source |
| Provincial Major Project | 湖南省科技重大专项“正清风痛宁(青风藤)全产业链技术研究” | 编号未公开 | 2020 | 项目首席专家 | Institutional / official media source | Source |
| SCI Paper | Beneficial effects of the extract from Corydalis yanhusuo in rats with heart failure following myocardial infarction | Journal of Pharmacy and Pharmacology|PMID 17524235 | 2007 | 共同作者 | Bibliographic record confirmed | Source |
| SCI Paper | Allicin improves cardiac function by protecting against apoptosis in rat model of myocardial infarction | Chinese Journal of Integrative Medicine|DOI 10.1007/s11655-016-2523-0 | 2016 | 作者 | Bibliographic record confirmed | Source |
| National Science & Technology Award | 血瘀证与活血化瘀研究(2003年国家科技进步一等奖,完成人排名第二) | 无 | 2003 | 第二完成人 | Institutional / official media source | Source |
| Chinese Core Journal | 国医大师翁维良治疗冠心病支架术后再狭窄的长时医案 | 天津中医药 2024|DOI 10.11656/j.issn.1672-1519.2024.08.02 | 2024 | 作者 | Bibliographic record confirmed | Source |
| National Science & Technology Award | 血瘀证与活血化瘀研究(2003年国家科技进步一等奖,完成人排名第三) | 无 | 2003 | 第三完成人 | Institutional / official media source | Source |
| National Science & Technology Award | 芪参益气滴丸对心肌梗死二级预防的临床试验(2011年国家科技进步二等奖) | 无 | 2011 | 主要完成人 | Institutional / official media source | Source |
| SCI Paper | Cardiovascular Disease, Mitochondria, and Traditional Chinese Medicine | Evidence-Based Complementary and Alternative Medicine|PMID 26074984 | 2015 | 第一作者 | Bibliographic record confirmed | Source |
| SCI Paper | Effectiveness and safety of Xuanbi Antong granules for borderline coronary lesions | BMJ Open|PMID 31399446 | 2019 | 通讯作者 | Bibliographic record confirmed | Source |
| SCI Paper | Innovative Strategy in Treating Angina Pectoris with Chinese Patent Medicines | Current Vascular Pharmacology|PMID 25360837 | 2015 | 作者 | Bibliographic record confirmed | Source |
| Granted Patent | 一种含有丹参和三七成分的多组分同步均衡释药长效制剂 | CN103127221B | 2013 | 发明人 | Cross-verified in patent databases | Source |
| National Research Project | 国家自然科学基金面上项目“冠心病稳定型心绞痛痰瘀互结证多组学网络模块整合研究” | 81974556 | 2019 | 负责人 | Bibliographic record confirmed | Source |
| SCI Paper | Advances and challenges in ginseng research from 2011 to 2020 | Natural Product Reports|PMID 35128553 | 2022 | 通讯作者 | Bibliographic record confirmed | Source |
| SCI Paper | Approaches to establish Q-markers for the quality standards of traditional Chinese medicines | Acta Pharmaceutica Sinica B|PMID 28752028 | 2017 | 通讯作者 | Bibliographic record confirmed | Source |
| SCI Paper | Comprehensive Saponin Profiling and Comparison of Ten Panax Species | J Agricultural and Food Chemistry|PMID 42109256 | 2026 | 通讯作者 | Bibliographic record confirmed | Source |
| Granted Patent | 一种治疗心血管疾病的口腔崩解片及制备方法 | CN101028338B | 2007 | 第一发明人 | Cross-verified in patent databases | Source |
| Granted Patent | 治疗心血管疾病的中药有效成分组合物及其制备方法 | CN100563662C | 2007 | 第一发明人 | Cross-verified in patent databases | Source |
| National Research Project | 国家自然科学基金重点项目“以通心络胶囊和半夏泻心汤为载体的中药复方质量评价方法及关键技术研究” | 82130111 | 2021 | 主持 | Institutional / official media source | Source |
| SCI Paper | Antimicrobial activities of lavandulylated flavonoids in Sophora flavences against MRSA | Journal of Advanced Research|PMID 37137428 | 2024 | 通讯作者 | Bibliographic record confirmed | Source |
| SCI Paper | Comparative analysis of sixteen flavonoids from different parts of Sophora flavescens Ait. | J Pharmaceutical and Biomedical Analysis|PMID 29727783 | 2018 | 通讯作者 | Bibliographic record confirmed | Source |
| Granted Patent | 具酪氨酸酶抑制活性和抗菌活性的苦参黄酮类有效部位及其制备方法与应用 | CN109331061B | 2019 | 第一发明人 | Bibliographic record confirmed | Source |
| Granted Patent | 具有抵御视网膜蓝光损伤的药食两用组合物及其制备方法与应用 | CN111686208B | 2020 | 第一发明人 | Bibliographic record confirmed | Source |
| National Research Project | 973计划“基于『十八反』的中药配伍禁忌理论基础研究” | 2011CB505300 | 2011 | 首席科学家 | Institutional / official media source | Source |
| SCI Paper | Complete pathway elucidation of echinacoside in Cistanche tubulosa and de novo biosynthesis of phenylethanoid glycosides | Nature Communications|PMID 39837891 | 2025 | 通讯作者 | Verified on PubMed record | Source |
| SCI Paper | Molecular characterization and structure basis of a malonyltransferase from Cistanche tubulosa | Acta Pharmaceutica Sinica B|PMID 38799633 | 2024 | 通讯作者 | Bibliographic record confirmed | Source |
| SCI Paper | Glycosylation of Aromatic Glycosides by a Promiscuous Glycosyltransferase UGT71BD1 | Journal of Natural Products|PMID 35791759 | 2022 | 通讯作者 | Bibliographic record confirmed | Source |
| Granted Patent | 从肉苁蓉药材中提取分离松果菊苷的方法 | CN100345857C | 2007 | 发明人 | Cross-verified in patent databases | Source |
| Granted Patent | 肉苁蓉总苷及松果菊苷在制备用于预防和治疗酒精性肝损伤伴肠道损伤的药物中的应用 | CN113425764B | 2021 | 发明人 | Bibliographic record confirmed | Source |
| SCI Paper | Integration of Transcriptomics and Lipidomics Profiling to Reveal the Therapeutic Mechanism of Ramulus mori Alkaloids | Nutrients|PMID 37764698 | 2023 | 通讯作者 | Bibliographic record confirmed | Source |
| SCI Paper | Guan Xin Dan Shen formulation protects db/db mice against diabetic cardiomyopathy via activation of Nrf2 signaling | Molecular Medicine Reports|PMID 34036388 | 2021 | 通讯作者 | Bibliographic record confirmed | Source |
| Granted Patent | 一类具有抗纤维化功能的三萜类化合物及其制备方法 | CN112574273B | 2021 | 发明人 | Cross-verified in patent databases | Source |
| National Research Project | 973计划“确有疗效的有毒中药科学应用关键问题的基础研究” | 2009CB522805 | 2009 | 负责人 | Bibliographic record confirmed | Source |
| National Research Project | 国家重大新药创制专项“早期成药性评价关键技术” | 2012ZX09501001 | 2012 | 负责人 | Bibliographic record confirmed | Source |
| SCI Paper | A review of herb-induced liver injury in mainland china | Frontiers in Pharmacology|PMID 36304164 | 2022 | 通讯作者 | Bibliographic record confirmed | Source |
| SCI Paper | Yin/Yang associated differential responses to Psoralea corylifolia Linn. in rat models | Chinese Medicine|PMID 37592331 | 2023 | 通讯作者 | Bibliographic record confirmed | Source |
| SCI Paper | Reynoutria multiflora combined with Cullen corylifolium enhances idiosyncratic hepatotoxicity | Journal of Ethnopharmacology|PMID 40383245 | 2025 | 通讯作者 | Bibliographic record confirmed | Source |
| Granted Patent | 一种治疗酒精性肝病的中药组合物及其制备方法 | CN105362997B | 2019 | 发明人 | Cross-verified in patent databases | Source |
| National Research Project | 国家自然科学基金重点项目(中药药源性/特异质肝损伤方向) | 81630100 | 2016 | 负责人 | Bibliographic record confirmed | Source |
| SCI Paper | Cytokine Storm in Acute Viral Respiratory Injury: Role of Qing-Fei-Pai-Du Decoction | The American Journal of Chinese Medicine|PMID 37403214 | 2023 | 通讯作者 | Bibliographic record confirmed | Source |
| SCI Paper | Comprehensive profiling of absorbed components and metabolites of Qing-Fei-Pai-Du decoction | Chinese Journal of Natural Medicines|PMID 33875170 | 2021 | 通讯作者 | Bibliographic record confirmed | Source |
| Granted Patent | 一种用于治疗肝脏疾病的中药组合物及其制备方法 | CN100406027C | 2008 | 第一发明人 | Cross-verified in patent databases | Source |
| National Research Project | 国家重点研发计划“基于系统生物学的中成药临床疗效与安全性评价关键技术的建立与示范研究” | 编号未公开 | 2022 | 负责人 | Institutional / official media source | Source |
| SCI Paper | Panax notoginseng saponins alleviates inflammation induced by microglial activation | Biomedicine & Pharmacotherapy|PMID 36271540 | 2022 | 通讯作者 | Bibliographic record confirmed | Source |
| SCI Paper | Repeated administration of Sailuotong for vascular dementia alters CYP450 activities in rats | Phytomedicine|PMID 29425645 | 2018 | 通讯作者 | Bibliographic record confirmed | Source |
| Granted Patent | 一种治疗缺血性中风及中风后抑郁的中药组合物及其制法 | CN104958572B | 2015 | 第一发明人 | Cross-verified in patent databases | Source |
| Granted Patent | 一种治疗气虚证的中药组合物及其制备方法和用途 | CN113952377B | 2022 | 发明人 | Bibliographic record confirmed | Source |
| National Research Project | 973计划“基于病证结合的气血相关理论研究” | 2015CB554400 | 2015 | 项目负责人 | Institutional / official media source | Source |
| National Research Project | 国家自然科学基金重点项目“血瘀证发生与演变的血小板系统生物学机制研究” | 82030124 | 2020 | 负责人 | Institutional / official media source | Source |
| SCI Paper | Isodonoids A-L: Ent-kauranoid diterpenoid-flavanone conjugates from Isodon rubescens | Phytochemistry|PMID 42097260 | 2026 | 通讯作者 | Bibliographic record confirmed | Source |
| SCI Paper | Oligosaccharide mapping analysis through UPLC-Orbitrap-HRMS from Polygonatum odoratum | Carbohydrate Polymers|PMID 41475737 | 2026 | 通讯作者 | Bibliographic record confirmed | Source |
| Published Application | 基于深度学习的中药材目标检测相关中国发明专利(2件,仅检索到申请公布号) | CN114818874A;CN114821554A | 2022 | 团队发明人 | Bibliographic record confirmed | Source |
| Provincial Research Project | 澳门科学技术发展基金重点研发专项(中药材图像数据库与深度学习检测) | 0023/2019/AKP | 2019 | 负责人 | Institutional / official media source | Source |
| SCI Paper | WRKY44 represses expression of the wound-induced sesquiterpene biosynthetic gene ASS1 in Aquilaria sinensis | Journal of Experimental Botany|PMID 31639819 | 2020 | 通讯作者 | Bibliographic record confirmed | Source |
| SCI Paper | Genome-wide identification of the histone modification gene family in Aquilaria sinensis | International Journal of Biological Macromolecules|PMID 39357718 | 2024 | 通讯作者 | Bibliographic record confirmed | Source |
| SCI Paper | Genome-wide analysis of bHLH transcription factors in Aquilaria sinensis | Scientific Reports|PMID 35505005 | 2022 | 通讯作者 | Bibliographic record confirmed | Source |
| Granted Patent · China Patent Excellence Award | 输液法在白木香树上生产沉香的方法(通体结香技术核心专利) | CN101755629B|2015年获第十七届中国专利优秀奖 | 2010 | 第一发明人 | Institutional / official media source | Source |
| National Research Project | 国家重点研发计划“中医药现代化研究”重点专项《名贵南药沉香大品种开发关键技术突破与产业化应用》 | 2018YFC1706400 | 2018 | 项目负责人 | Institutional / official media source | Source |
| SCI Paper | Sedative and hypnotic effects of compound Anshen essential oil inhalation for insomnia | BMC Complementary and Alternative Medicine|PMID 31711477 | 2019 | 通讯作者(yangming16@126.com) | Verified on PubMed record | Source |
| SCI Paper | Natural volatile oils derived from herbal medicines: A promising therapy way for treating depressive disorder | Pharmacological Research|PMID 33316383 | 2021 | 通讯作者 | Bibliographic record confirmed | Source |
| SCI Paper | Rosemary (Rosmarinus officinalis L.) hydrosol based on serotonergic synapse for insomnia | Journal of Ethnopharmacology|PMID 37532071 | 2023 | 共同通讯作者(第一完成单位为陕西中医药大学) | Verified on PubMed record | Source |
| Granted Patent | 镇静安神的中药组合物、中药缓释香囊及其制备方法 | CN108888675B(申请号 CN201810912903.5,授权日 2021-03-09) | 2021 | 共同发明人 | Cross-verified in patent databases | Source |
| Published Application | 洗发水及其制备方法(中药精油微胶囊,挥发油包合) | CN114028309A | 2022 | 团队发明人 | Bibliographic record confirmed | Source |
| National Research Project | 国家自然科学基金面上项目“基于组分药动学的地榆升白『组分药对』相恶配伍规律的研究” | 81373976 | 2013 | 负责人 | Institutional / official media source | Source |
| National Research Project | “十一五”重大新药创制科技重大专项:中药集成创新技术平台 | 2009ZX09313-004 | 2009 | 负责人 | Institutional / official media source | Source |
| Granted Patent | 一种苍艾香薰油(苍术、艾叶、藿香、佩兰、丁香等,经鼻吸入;2020年以43万元转让企业) | CN201310388088.4 | 2013 | 第一发明人 | Bibliographic record confirmed | Source |
| Published Application | 经皮吸收的苍艾油传递体凝胶及其制备方法 | CN112022919A | 2020 | 发明人 | Bibliographic record confirmed | Source |
| Academic Monograph | 《芳香中药学》(国内首部) | ISBN 9787513271653|中国中医药出版社 | 2022 | 主编 | Institutional / official media source | Source |
| Chinese Core Journal | 基于7.0T心脏磁共振成像探讨苍艾挥发油对正常大鼠心功能的影响 | 中成药 2022,44(3)|DOI 10.3969/j.issn.1001-1528.2022.03.011 | 2022 | 通讯作者 | Bibliographic record confirmed | Source |
| National Research Project | 国家自然科学基金地区科学基金“苍艾挥发油经鼻给药对肺气虚型大鼠免疫作用机制研究” | 81160534 | 2011 | 负责人 | Bibliographic record confirmed | Source |
| National Research Project | NSFC“应用phfMRI研究苍艾挥发油的经鼻脑靶向作用和对抑郁症大鼠脑内单胺类神经递质通路的影响” | 81560740 | 2015 | 负责人 | Bibliographic record confirmed | Source |
| Chinese Core Journal | 落花生枝叶制剂治疗失眠症疗效观察(458例临床观察) | 上海中医药杂志 2001(5)|DOI 10.16305/j.1007-1334.2001.05.002 | 2001 | 第一作者 | Bibliographic record confirmed | Source |
| Academic Monograph | 《花生枝叶治失眠——20年研究硕果》 | ISBN 9787543938090|上海科学技术文献出版社 | 2009 | 主编 | Institutional / official media source | Source |
| Published Application | 一种落花安神口服液及其制备方法和应用 | CN108186713A | 2018 | 共同发明人 | Bibliographic record confirmed | Source |
| SCI Paper | Efficacy and Safety of Electroacupuncture on Treating Depression Related Sleep Disorders | Evidence-Based Complementary and Alternative Medicine|PMID 28119755 | 2016 | 作者 | Bibliographic record confirmed | Source |
| Granted Patent | 一种治疗肝郁型失眠的中药组合物及其应用(落花生枝叶+制香附药对) | CN115364164B | 2022 | 第一发明人 | Cross-verified in patent databases | Source |
| Published Application | 一种治疗失眠症的中药组合物及其应用(平肝解郁、清热活血安神方) | CN104056088A | 2014 | 共同发明人 | Bibliographic record confirmed | Source |
| National Project | 国家临床重点专科(神志病/睡眠疾病)建设项目 + 国家重大新药创制项目 | 编号未公开 | — | 负责人/承担人 | Institutional / official media source | Source |
| Chinese Core Journal | 催眠状态下的意念导入性心理治疗 | 中国临床心理学杂志 2010,18(6):817 | 2010 | 第一作者 | Bibliographic record confirmed | Source |
| Academic Monograph | 《低阻抗意念导入疗法——“TIP技术”的理论与实践》 | ISBN 9787117150293|人民卫生出版社 | 2011 | 主编 | Institutional / official media source | Source |
| National Research Project | NSFC“中医非药物疗法治疗抑郁症伴失眠的机制研究” | 30772845 | 2007 | 负责人 | Bibliographic record confirmed | Source |
| Academic Monograph | 《中医睡眠医学》 | ISBN 9787117053945|人民卫生出版社 | 2003 | 主编 | Institutional / official media source | Source |
| Chinese Core Journal | 发作性睡病患者的血清EB病毒回顾性分析研究 | 世界睡眠医学杂志 2018,5(1)|DOI 10.3969/j.issn.2095-7130.2018.01.013 | 2018 | 通讯作者 | Bibliographic record confirmed | Source |
| National Research Project | 中国中医科学院科技创新工程重大攻关项目 | CI2021A02211 | 2021 | 论文基金标注(承担角色未明确) | Bibliographic record confirmed | Source |
| SCI Paper | Ginsenoside Rg1 alleviates PCPA-induced insomnia by inhibiting NLRP3 inflammasome activation and pyroptosis through the Nrf2/HO-1 pathway in mice | Psychopharmacology (Berl)|PMID 40493075 | 2025 | 通讯作者(福建省中医药科学院) | Verified on PubMed record | Source |
| Granted Patent | 一种昼夜组合式助眠香囊及其制备方法(夜方:合欢花/夜交藤/檀香;昼方:甘松/薄荷/玫瑰花) | CN113893292B(授权日 2022-05-24) | 2022 | 第一发明人 | Cross-verified in patent databases | Source |
| Granted Patent | 一种辅助治疗失眠的外用贴剂(黄连、夜交藤、肉桂,穴位敷贴巴布剂) | CN103550321B(授权日 2015-06-17) | 2015 | 第一发明人 | Bibliographic record confirmed | Source |
| National Research Project | 国家重点研发计划“中医药现代化研究”重点专项子课题:中药联合认知行为、运动、音乐、芳香等综合疗法防治失眠的方案优化 | 2018YFC1705600 | 2018 | 负责人 | Institutional / official media source | Source |
| National Research Project | NSFC面上项目“基于阴阳寤寐学说的交泰丸及其拆方对睡眠时相的影响及调节GABA信号通路的作用” | 81774285 | 2017 | 负责人 | Bibliographic record confirmed | Source |
| Chinese Core Journal | 交泰丸对睡眠剥夺大鼠下丘脑GABA受体基因表达的影响 | 世界睡眠医学杂志 2021,8(11)|DOI 10.3969/j.issn.2095-7130.2021.11.002 | 2021 | 通讯作者 | Bibliographic record confirmed | Source |
| SCI Paper |
New Alkaloids from Lycopodium japonicum
从伸筋草全草乙醇提取物中分离鉴定 3 个新生物碱及 10 个已知生物碱,结构经 MS、NMR 波谱确证。
|
Chemical & Pharmaceutical Bulletin|PMID 22971777 | 2012 | 通讯作者(沈云亨、张卫东) | Verified on PubMed record | Source |
| SCI Paper |
Inhalation Aromatherapy via Brain-Targeted Nasal Delivery: Natural Volatiles or Essential Oils on Mood Disorders
系统阐明精油/挥发油可经鼻—脑通路绕过血脑屏障靶向脑组织,作用于大脑皮层、丘脑与边缘系统,改善焦虑、抑郁与睡眠质量;综述近十年临床与动物实验证据。被引 124 次。
|
Frontiers in Pharmacology|PMID 35496310 | 2022 | 通讯作者(与秦冬冬、明溪共同通讯) | Verified on PubMed record | Source |
| SCI Paper |
Lycopodine-Type Alkaloids from Lycopodium japonicum
从伸筋草(石松)中分离得到 3 个新 lycopodine 型生物碱:4α-hydroxyanhydrolycodoline、4α,6α-dihydroxyanhydrolycodoline、6-epi-8β-acetoxylycoclavine,另含 17 个已知化合物。
|
Natural Products and Bioprospecting|PMID 25089239 | 2014 | 通讯作者 | Verified on PubMed record | Source |
| SCI Paper |
Screen the Effective Components of Lycopodii herba on Rheumatoid Arthritis with the Aid of Spectrum-Effect Relationship and Uncover its Potential Mechanism
RA 动物模型:各伸筋草样品给药组后足足爪容积及 RF、TNF-α、IL-1β 水平均低于模型组;UPLC-Q-TOF/MS 指纹图谱+谱效关系确定主要药效成分为 lycojaponicumin C、des-N-methyl-α-obscurine 等石松生物碱;机制与 AChE/NF-κB 通路相关。原文仅报告『降低』,未给出具体百分比。
|
Inflammation|PMID 32914364 | 2020 | 通讯作者(Zhang Yanjun;共同通讯 Guo Hong) | Verified on PubMed record | Source |
| SCI Paper |
Mechanism of Lycopodii herba for RA-ILD using integrated metabolomics and network pharmacology
RA-ILD 大鼠模型:血清中鉴定出 15 个伸筋草潜在生物标志物,主要关联醚脂代谢与花生四烯酸代谢;网络药理学获 21 条相关通路;机制可能为调控 PLA2G1B 与 PI3KCA 表达。
|
Analytical Biochemistry|PMID 35367217 | 2022 | 通讯作者 | Verified on PubMed record | Source |
| Chinese Core Journal |
伸筋草乙醇提取物对佐剂性关节炎大鼠类风湿因子和血清细胞因子的影响
大鼠佐剂性关节炎模型,ELISA 测 RF 与 IL-1β、放射免疫法测 TNF-α、IL-6:不同剂量伸筋草乙醇提取物均能显著抑制继发病变并降低上述指标(原文为定性结论)。该文被引 45 次。
|
中医药信息|2008(3)|基金:黑龙江省科技厅攻关计划 GC05C414 | 2008 | 合著者(团队指导者) | Bibliographic record confirmed | Source |
| Chinese Core Journal |
伸筋草药材 UPLC 指纹图谱的鉴别研究
建立伸筋草 UPLC 特征指纹图谱,标定 19 个共有峰,10 批药材相似度 0.923—0.985,与混淆品差异明显;另有 HPLC 版标定 40 个共有峰,11 批相似度 0.903—0.961。可作为伸筋草原料真伪鉴别的公开方法学依据。
|
中国实验方剂学杂志 2013 | 2013 | 通讯作者 | Bibliographic record confirmed | Source |
| Chinese Core Journal |
基于药性特征的中药挥发油透皮促渗「热者易效」规律与机制
关键数据:①有报道的 42 种中药挥发油促渗剂中温热药性占 32 种(76.2%);②使用浓度 0.25%—10.00%,以 1%—5% 为主;③促渗能力『热>温>寒凉』;④川芎油 15% 浓度下皮肤血流灌注量达对照组 4.81 倍,合用缩血管药后离体促渗不受影响但在体显著下降,证明『活血』为重要促渗机制;⑤提出倍半萜角质层贮库效应与 TRPM8/TRPV1/TRPV4 机制假说。
|
中草药 2024|基金:国自然面上项目 82173994 | 2024 | 第一作者兼通信作者(与段金廒共同通信) | Bibliographic record confirmed | Source |
| National Research Project |
基于倍半萜角质层贮库效应的辛味中药挥发油透皮促渗「热者易效」机制研究
执行期 2022-01 至 2025-12,直接经费 55 万元;为『热敷+草本挥发油』协同增效提供了国家自然科学基金项目层面的机制研究支撑。
|
国家自然科学基金面上项目 82173994 | 2022 | 主持 | Institutional / official media source | Source |
| National Science & Technology Award |
国家科学技术进步奖一等奖(主要完成人)
官方页面表述为『获国家科技进步一等奖 1 项(主要完成人)』,另获省部级一等奖多项;具体年度与奖励编号未在官网公布,未作填充。
|
奖励编号未公开|来源:河南中医药大学官网 | — | 主要完成人 | Institutional / official media source | Source |
| Academic Monograph |
中药外用共性技术平台与中药安全外用专业数据库;牵头起草发布中医药标准规范 46 项
创建中药外用共性技术平台、中药毒理学与本草外用学,开拓『中药鲜药』『中药配方精油』研究领域;国家发明专利 36 项;发表中文核心 700 余篇、SCI 70 余篇。具体专利号与标准号未在官网逐条公布,未作填充。
|
标准编号未公开|来源:河南中医药大学官网 | — | 创建者 / 牵头起草人 | Institutional / official media source | Source |
| National Research Project |
国家重点研发计划课题 1 项、国家自然科学基金项目 4 项(项目编号未公开)
官方页面表述为『主持国家重点研发计划课题 1 项、国家自然科学基金项目 4 项』;具体项目编号未在官网公布,未作填充,建议以国自然 ISIS 系统核验。
|
编号未公开|来源:贵州中医药大学药学院官网 | — | 主持 | Institutional / official media source | Source |
| Granted Patent |
骨康胶囊、化风丹、理气活血滴丸等中药新药研发(授权专利 20 余件,具体 CN 号未公开)
官方页面表述为『申请发明专利 30 余件、获授权 20 余件(转让 11 件)』,主持研发品种累计销售产值超 100 亿元;获教育部科技进步二等奖 1 项、贵州省科技进步一等奖 1 项。具体专利号未逐条公布,未作填充。
|
授权专利 20 余件|来源:贵州中医药大学药学院官网 | — | 主持研发 | Institutional / official media source | Source |
| SCI Paper |
Efficacy of Sanhua essential oil inhalation in patients with breast cancer-related depression undergoing chemotherapy: A randomized, single-masked, placebo-controlled clinical trial
随机单盲安慰剂对照,2023 年 3—12 月招募 144 例,最终分析精油组 52 例/安慰剂组 52 例;三花精油(玫瑰、代代花、丁香)每日吸入 1 次×21 天,对照吸入葵花籽油。结果:抑郁改善有效率 48.1% vs 21.2%(P=0.010);HAMD24(P=0.017)、中医症状评分(P=0.002)、PSQI(P=0.005)均优于对照;fMRI 显示左侧顶上回等功能连接组间差异显著。
|
Journal of Traditional Chinese Medical Sciences|DOI 10.1016/j.jtcms.2025.05.003 | 2025 | 通讯作者 | Bibliographic record confirmed | Source |
| National Research Project |
SD-265 睡眠紊乱管理法入选国家重点研发计划「中医药现代化」重点专项
昼夜 6 种干预手段(白昼:光照、运动、时辰管理;夜间:中药口服、中药浴足、挥发油导眠)+五脏功能动态评价。其中『夜间挥发油导眠』与本品牌芳香助眠方向直接对应。
|
项目编号未公开 | 2018 | 方法创立者/团队负责人 | Institutional / official media source | Source |
| Academic Monograph |
《多导睡眠仪实用技术手册》(主编)
我国早期系统规范 PSG 操作流程的口袋书,为睡眠医学临床检测标准化提供参考。
|
出版社信息未检索到 | — | 主编 | Institutional / official media source | Source |
| Chinese Core Journal |
从水、火、气、血辨治失眠
基于营卫失和与津液输布理论,将失眠分为水证、火证、气证、血证,各分不足与有余两大类辨治。
|
中华中医药杂志 2025,40(1):261 | 2025 | 通信作者 | Bibliographic record confirmed | Source |
| National Science & Technology Award |
《中医治未病健康辨识与干预关键技术创建及推广应用》——2022 年度广东省科技进步一等奖
制定国家治未病建设方案及评价体系,牵头多项指南标准,被国家卫健委和国家中医药局推荐应用于 700 余家医疗机构。
|
广东省科技进步一等奖 | 2022 | 团队带头人 | Institutional / official media source | Source |
| National Research Project |
国家重点研发计划「中医药现代化研究」重点专项——慢性失眠中医诊疗新方案及机制研究
标志性成果为《成人慢性失眠中医诊疗专家共识》;项目编号由合作单位甘肃中医药大学论文基金标注交叉印证。
|
2018YFC1705600 | 2018 | 项目首席科学家 | Institutional / official media source | Source |
| Chinese Core Journal |
基于分子对接和分子动力学模拟探讨生慧颗粒作用于 GABAaR 和 AChE 的机制
生慧颗粒 26 个活性成分中 18 个对 GABAaR 的对接优于地西泮,最佳成分为毛蕊花糖苷(Acteoside),30 ns 分子动力学模拟结合能 −29.60±3.53 kcal/mol;4 个成分优于多奈哌齐。
|
中华中医药杂志 2024,39(1):157-162 | 2024 | 通信作者 | Bibliographic record confirmed | Source |
| Published Application |
一种安寐颗粒及其制备方法
处方(质量份):人参 6-12、丹参 4-8、麦冬 6-12、甘草 2-4、茯神 6-12、生枣仁 10-20、熟枣仁 10-20、石菖蒲 2-4、当归 6-12、五味子 2-4;水煎 3 次喷雾干燥制粒。仅检索到申请公布号,未确认授权。
|
CN113181123A(申请号 202110518981.9) | 2021 | 第一发明人 | Cross-verified in patent databases | Source |
| Published Application |
培元健脑、安神益智的中药组合物及其制备方法和应用
处方:熟地黄、山茱萸、远志、生酸枣仁、柏子仁、茯神、人参、石菖蒲、白芥子;减轻海马神经元—突触损伤、促进海马神经发生、调控生物钟基因表达。仅检索到申请公布号。
|
CN115844979A(申请号 202211412488.X) | 2023 | 第一发明人 | Cross-verified in patent databases | Source |
| National Research Project |
国家重点研发计划「中医药现代化」重点专项课题——失眠及其与更年期综合征、高血压、老年轻度认知障碍等相关病症的关系及综合治理方案研究
项目编号源自其团队论文基金标注(甘肃中医药大学机构知识库);为国内慢性失眠共病综合干预的首个国家级重点专项课题。
|
2018YFC1705604 | 2018 | 课题负责人 | Institutional / official media source | Source |
| Chinese Core Journal |
失眠机理的中西医研究进展
综述:失眠与 GABA、褪黑素、5-HT 等抑制性神经递质不足、HPA 轴过度活跃及炎症因子密切相关;中医病机总属阳盛阴衰、阴阳失交,病位在心,与肝脾肾相关。被引 26 次。
|
中国社区医师 2021,37(14)|基金:2018YFC1705600 / 2018YFC1705604 | 2021 | 通信作者 | Bibliographic record confirmed | Source |
| Chinese Core Journal |
杨文明治疗不寐经验
题录源自国家中医药管理局名词术语规范推广项目审核的大医词条;未获取全文。
|
中医药临床杂志 2017,29(8):1234-1236 | 2017 | 经验主体(被整理名医) | Bibliographic record confirmed | Source |
| Chinese Core Journal |
睡眠健康管理系统应用于失眠患者的临床研究
120 例失眠障碍患者随机分为常规治疗组与睡眠管理组;睡眠管理组 PSQI、GAD-7、PHQ-9、DBAS-16 及中医症候量化评分均明显降低,中西医临床疗效均高于常规治疗组(P<0.05)。原文未披露 PSQI 绝对分值。
|
中国现代医生 2024,62(6):19-23|DOI 10.3969/j.issn.1673-9701.2024.06.005 | 2024 | 通信作者 | Bibliographic record confirmed | Source |
| Provincial Research Project |
浙江省基础公益研究计划项目(睡眠健康管理/慢性失眠情志方向)
省级项目(非国家级),支撑上述睡眠临床研究论文。
|
LGF21H270010 | 2021 | 主持 | Bibliographic record confirmed | Source |
| SCI Paper |
Leptin receptor neurons in the ventral premammillary nucleus modulate emotion-induced insomnia
小鼠尿液、大鼠尿液、TMT 等情绪性刺激激活 PMv 中 LepR 神经元引起失眠(n=6,EEG/EMG 记录);化学遗传学抑制该群神经元可消除情绪刺激诱发的失眠,而不影响生理性睡眠—觉醒。基金:82020108014、32070984、82170104 等。
|
Cell Discovery|PMID 38830876 | 2024 | 共同通信作者 | Verified on PubMed record | Source |
| SCI Paper |
Ambient Chemical and Physical Approaches for the Modulation of Sleep and Wakefulness
系统综述 200 篇成果,梳理光、温度、气味等环境理化因素对睡眠觉醒的作用与机制,指出腹侧前乳头体核、上丘、背内侧下丘脑及嗅球、嗅结节等参与调控。气味调控睡眠的权威综述,是芳香助眠方向最重要的机制学背书。
|
Sleep Medicine Reviews|DOI 10.1016/j.smrv.2024.102015 | 2024 | 共同通信作者 | Institutional / official media source | Source |
| National Research Project |
科技创新 2030「脑科学与类脑研究」重大项目——睡眠觉醒调控机制
复旦官方页面表述为『牵头科技创新 2030 国家脑计划重大项目』;另主持国自然重点、杰青、重点国际合作及国家新药创制重大专项。
|
编号未公开 | — | 牵头人(首席科学家) | Institutional / official media source | Source |
| SCI Paper |
Activation of GABA type A receptor is involved in the anti-insomnia effect of Huanglian Wendan Decoction
在表达 α1β3γ2L GABA_A 受体的 HEK293 细胞中,黄连温胆汤显著增强 GABA 诱发电流;100 μM 下 (+)-Cuparene 增效 278.80%±19.13%、Ethyl glucoside 225.40%±21.77%、β-Caryophyllene 290.11%±17.71%,均为正向变构调节剂;Ethyl glucoside 在 PCPA 诱导斑马鱼失眠模型中 100 μM 显示抗失眠作用。
|
Frontiers in Pharmacology|DOI 10.3389/fphar.2024.1389768 | 2024 | 共同通信作者 | Bibliographic record confirmed | Source |
| National Research Project |
国家自然科学基金面上项目——四逆散治疗失眠的药效物质基础及作用机制研究
批准金额 25 万元,执行 2007-01 至 2009-12;确定四逆散改善睡眠药效物质为辛弗林、芍药苷、柴胡皂苷 C、甘草次酸(8.5:1:1.5:6.5)的混合物。
|
30672634 | 2006 | 负责人 | Institutional / official media source | Source |
| Chinese Core Journal |
从改善睡眠作用研究四逆散的疏肝解郁功效
四逆散可延长正常或睡眠剥夺大鼠慢波睡眠时间,影响脑内多种神经递质与睡眠相关因子,通过 GABA、NO、5-HT、P 物质、IL-1β、TNF-α 多途径多靶点实现。
|
世界科学技术-中医药现代化 2015(7):1367-1371|基金:30672634、81073077 | 2015 | 唯一作者/通信作者 | Bibliographic record confirmed | Source |
| Published Application |
改善睡眠作用的复方刺人参组合物及制备方法和用途
刺人参有效成分提取物(50% 乙醇回流+AB-8 大孔树脂 60% 乙醇洗脱部位)与刺五加有效成分提取物(水煎+D101 大孔树脂 50% 乙醇洗脱部位)按 2:1—5:1 配比。仅检索到申请公布号。
|
CN106074642A(申请号 201610428956.0) | 2016 | 申请人/第一发明人 | Cross-verified in patent databases | Source |
| Provincial Research Project |
五味子改善睡眠作用的药效物质基础及机制研究(成果登记)
基于夜间睡眠参数、觉醒水平与日间功能三方面指标,阐明五味子木脂素改善跑步机睡眠剥夺大鼠睡眠的作用机制;发表国内外论文 10 篇,申报发明专利 1 项。
|
黑龙江中医药大学成果登记|研究起止 2019-07 至 2023-07 | 2024 | 第一完成人 | Institutional / official media source | Source |
| SCI Paper |
Acupuncture for chemotherapy-associated insomnia in breast cancer patients: an assessor-participant blinded, randomized, sham-controlled trial
138 例随机分组(各 69 例),15 次体针+耳穴按压,治疗 18 周、随访 24 周。主要终点 ISI 组间差异不显著(−0.4,95%CI −1.8~1.1,P=0.609),但主动针刺组在入睡潜伏期、总睡眠时间、睡眠效率、焦虑抑郁及生活质量方面短期与长期随访更优;镇静药停药率 56.5% vs 14.3%(P=0.011)。
|
Breast Cancer Research|DOI 10.1186/s13058-023-01645-0|NCT04144309 | 2023 | 末位/共同通信作者 | Bibliographic record confirmed | Source |
| SCI Paper |
Electroacupuncture Plus Auricular Acupressure for Chemotherapy-Associated Insomnia in Breast Cancer Patients: A Pilot Randomized Controlled Trial
30 例随机对照(28 例完成);第 6 周 ISI 组间差值 −2.9 分(95%CI −5.2~−0.6,P=0.014)利于针刺组;睡眠日记总睡眠时间(P=0.026)、PSQI(P=0.012)、HADS-抑郁(P=0.020)均显著改善。
|
Integrative Cancer Therapies|DOI 10.1177/15347354211019103 | 2021 | 通信作者 | Bibliographic record confirmed | Source |
| Chinese Core Journal |
经皮耳穴-迷走神经电刺激对原发性失眠患者默认网络的调制作用
22 例原发性失眠患者,取双侧耳穴心、肾,疏密波 4 Hz/20 Hz,每次 30 min、每日 2 次、每周≥5 d、共 4 周;治疗后 PSQI 总分降低(P<0.01);左侧 PCC 与左侧额中回功能连接值降低(P<0.05),右侧 PCC 与右内侧前额叶、左侧额中回 FC 值降低(P<0.001/P<0.01)。
|
中国针灸 2022(4) | 2022 | 作者之一(通信作者为荣培晶) | Bibliographic record confirmed | Source |
| National Research Project |
国家自然科学基金面上项目(耳穴电刺激治疗抑郁/失眠的脑机制)
项目编号源自其通信作者论文基金标注;项目名称未在检索结果中完整显示,建议以国自然官方 ISIS 系统核验。
|
82174282;81774433 | 2018—2022 | 主持 | Institutional / official media source | Source |
No matching records found.